Hadasit Bio-Holdings Ltd
Hadasit Bio-Holdings Ltd
Share · IL0010954050 (OTC)
Overview
No Price
Company Profile for Hadasit Bio-Holdings Ltd Share
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
AI Analysis of Hadasit Bio-Holdings Ltd
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Hadasit Bio-Holdings Ltd
No AI threads available for this company yet.

Company Data

Name Hadasit Bio-Holdings Ltd
Company Hadasit Bio-Holdings Ltd
Website https://www.hbl.co.il
Primary Exchange OTC UTC
ISIN IL0010954050
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Yuval Adar
Country Israel
Currency USD
Employees 0,0 T
Address Jerusalem Bio-Park, 91120 Jerusalem
IPO Date 2010-10-27
Dividends from 'Hadasit Bio-Holdings Ltd'
Ex-Date Dividend per Share
06.02.2019 0,59 ILS
07.02.2019 0,16 USD

Stock Splits

Date Split
11.08.2016 1:10
23.12.2009 833:500

Ticker Symbols

Name Symbol
Over The Counter HSITF
More Shares
Investors who hold Hadasit Bio-Holdings Ltd also have the following shares in their portfolio:
MURATA MFG
MURATA MFG Share
Spanien EO-Letras d.Tesoro 2025(26)
Spanien EO-Letras d.Tesoro 2025(26) Unbekannt
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026